The Delaware Compensation Rating Bureau (DCRB) has released its first Medical Treatment Statistics Report. Based on policy years 2018-2020, the report highlights workers compensation data for office and physical medicine visits, surgery, prescription drugs, and prescriptions with opioids.
READ NOW
As previously announced in DCRB Circular 1025, there will be a new reporting requirement for a series of Calendar-Accident Year Calls. Additional information is now available in the Financial section under the Data Reporting tab of our website.
READ NOW
The Delaware Department of Insurance has approved DCRB Amended Filing No. 2304, with overall changes of -13.85% in residual market rates and -10.03% in voluntary market loss costs.
READ NOW
To provide clarity around the rate approval filing processes, the Delaware Compensation Rating Bureau (DCRB) is issuing this information bulletin to notify members that the recent passage of Delaware House Bill No. 228 does not impact workers compensation insurance, and thus, all filing procedures for insurer workers compensation loss cost multiplier filings remain unchanged.
READ NOW
The Delaware Compensation Rating Bureau, Inc. (DCRB), a trusted, essential, and objective data collection organization supporting a healthy workers compensation system, is introducing a new form of communication for its membership.
READ NOW
The Delaware Compensation Rating Bureau (DCRB) has released its first Medical Treatment Statistics Report. Based on policy years 2018-2020, the report highlights workers compensation data for office and physical medicine visits, surgery, prescription drugs, and prescriptions with opioids.
Read Entry12/06/2023
As previously announced in DCRB Circular 1025, there will be a new reporting requirement for a series of Calendar-Accident Year Calls. Additional information is now available in the Financial section under the Data Reporting tab of our website.
Read Entry10/26/2023
The Delaware Department of Insurance has approved DCRB Amended Filing No. 2304, with overall changes of -13.85% in residual market rates and -10.03% in voluntary market loss costs.
Read Entry10/12/2023
To provide clarity around the rate approval filing processes, the Delaware Compensation Rating Bureau (DCRB) is issuing this information bulletin to notify members that the recent passage of Delaware House Bill No. 228 does not impact workers compensation insurance, and thus, all filing procedures for insurer workers compensation loss cost multiplier filings remain unchanged.
Read Entry09/28/2023
The Delaware Compensation Rating Bureau, Inc. (DCRB), a trusted, essential, and objective data collection organization supporting a healthy workers compensation system, is introducing a new form of communication for its membership.
Read Entry08/09/2023
The DCRB has published the 2022 audited financial statements along with the adjustment of assessment.
Read Entry08/07/2023